相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Efficacy and Safety of Entecavir Versus Adefovir in Chronic Hepatitis B Patients With Hepatic Decompensation: A Randomized, Open-Label Study
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Renal toxicity associated with tenofovir use
Sonia Rodriguez-Novoa et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
Gloria Woo et al.
GASTROENTEROLOGY (2010)
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection
Thomas Berg et al.
GASTROENTEROLOGY (2010)
Entecavir in decompensated HBV cirrhosis: The future is looking brighter
Robert J. Fontana
JOURNAL OF HEPATOLOGY (2010)
TREATMENT OF DECOMPESATED HBV-CIRRHOSIS: RESULTS FROM 2-YEARS RANDOMIZED TRIAL WITH TELBIVUDINE OR LAMIVUDINE
E. J. Gane et al.
JOURNAL OF HEPATOLOGY (2010)
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus
Chia-Ming Chu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Side Effects of Long-Term Oral Antiviral Therapy for Hepatitis B
Robert J. Fontana
HEPATOLOGY (2009)
Severe Lactic Acidosis During Treatment of Chronic Hepatitis B with Entecavir in Patients with Impaired Liver Function
Christian M. Lange et al.
HEPATOLOGY (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B
Russell D. Fleischer et al.
JOURNAL OF HEPATOLOGY (2009)
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure
Fabien Zoulim et al.
LIVER INTERNATIONAL (2009)
Efficacy and Safety of Entecavir in Patients With Chronic Hepatitis B and Advanced Hepatic Fibrosis or Cirrhosis
Eugene Schiff et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis
Tomohiro Nishida et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list
Melissa K. Osborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma
Stephen N. Wong et al.
LIVER TRANSPLANTATION (2007)
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results
Eugene Schiff et al.
LIVER TRANSPLANTATION (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis
YF Liaw et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus
KM Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2005)
Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis
PL Tseng et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B
N Nikolaidis et al.
CLINICAL TRANSPLANTATION (2005)
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
JOURNAL OF VIRAL HEPATITIS (2004)
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
F van Bömmel et al.
HEPATOLOGY (2004)
Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection
S Manolakopoulos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
SJ Hadziyannis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis
HWL Hann et al.
LIVER TRANSPLANTATION (2003)
Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation
P Andreone et al.
TRANSPLANTATION (2002)
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B
RJ Fontana et al.
LIVER TRANSPLANTATION (2002)
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis
RP Perrillo et al.
HEPATOLOGY (2001)
A model to predict survival in patients with end-stage liver disease
PS Kamath et al.
HEPATOLOGY (2001)
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
FY Yao et al.
JOURNAL OF HEPATOLOGY (2000)
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
JP Villeneuve et al.
HEPATOLOGY (2000)
分享论文
